4
Changes in Ownership
Emergent BioSolutions Inc. Filed Acc 0000899243-20-005195
Chairman sold 20,000 shares at $63.90 ($1,278,000)
- Chairman acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| El-Hibri Fuad Chairman | 2020-02-14 | Option exercise | +4,386 | $25.62 | $112,369 | 1,483,404 | D |
| El-Hibri Fuad Chairman | 2020-02-14 | Sale | −4,386 | $63.90 | $280,265 | 1,479,018 | D |
| El-Hibri Fuad Chairman | 2020-02-18 | Option exercise | +15,614 | $25.62 | $400,031 | 1,494,632 | D |
| El-Hibri Fuad Chairman | 2020-02-18 | Sale | −15,614 | $63.90 | $997,735 | 1,479,018 | D |
| Derivatives | |||||||
| El-Hibri Fuad Chairman | 2020-02-14 | Option exercise · Employee Stock Options (Right to Buy) | −4,386 | 38,932 | D | ||
| El-Hibri Fuad Chairman | 2020-02-18 | Option exercise · Employee Stock Options (Right to Buy) | −15,614 | 23,318 | D | ||
| Open-market sales · 20,000 sh · avg $63.90 · $1,278,000 | |||||||
Loading xslF345X03/doc4.xml…